The global Preimplantation Genetic Testing Market is on a robust growth trajectory, driven by a convergence of demographic trends, technological advancements, and a growing societal focus on reproductive health. According to a comprehensive report by Market Research Future, the market was valued at USD 2.11 billion in 2024. It is projected to grow from USD 2.26 billion in 2025 to USD 4.492 billion by 2035, registering a Compound Annual Growth Rate (CAGR) of 7.11% during the forecast period.

This expansion is a direct response to the increasing global demand for assisted reproductive technologies (ART), particularly in vitro fertilization (IVF). A primary driver is the rising incidence of infertility. The World Health Organization estimates that infertility affects approximately 1 in 6 people globally, a statistic that underscores the immense and growing need for effective reproductive solutions. Factors such as delayed childbearing, lifestyle changes, and environmental influences are contributing to these numbers, prompting more individuals and couples to seek medical assistance to build their families.

Preimplantation genetic testing (PGT) has emerged as a critical component of modern IVF. It allows embryologists and geneticists to analyze embryos created through IVF for specific genetic abnormalities before they are transferred to the uterus. This capability serves multiple vital purposes: it can identify embryos carrying genes for serious hereditary diseases, screen for chromosomal abnormalities (aneuploidy) that are a leading cause of IVF failure and miscarriage, and aid in selecting the most viable embryo for transfer. By doing so, PGT significantly enhances the chances of a successful pregnancy and the birth of a healthy child.

Geographically, North America leads the market, holding over 42.65% of the global share, a testament to its advanced healthcare infrastructure, high acceptance of genetic testing, and supportive regulatory environment. However, the fastest-growing opportunities lie in the Asia-Pacific region, where rising healthcare expenditures, increasing medical tourism for fertility treatments, and growing awareness are fueling rapid market expansion. As technology continues to advance and societal acceptance grows, the PGT market is set to play an increasingly central role in the future of family planning.